Market Cap 25.08M
Revenue (ttm) 0.00
Net Income (ttm) -11.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 151,300
Avg Vol 161,652
Day's Range N/A - N/A
Shares Out 32.56M
Stochastic %K 15%
Beta 1.60
Analysts Strong Sell
Price Target $8.38

Company Profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatmen...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 9 799 6183
Address:
Building B, 11 HaMenofim Street, Herzliya, Israel
lev57
lev57 May. 19 at 7:29 PM
He changes that they will not exceed him in portions of 200. Who sells and buys immediately. In order to lower the rate. The SEC follows you. And a bill will come with you.$NRSN
1 · Reply
lev57
lev57 May. 19 at 4:18 PM
A gentleman gave 100. Who sells and buys immediately. In order to lower the rate. The SEC follows you. And a bill will come with you.$NRSN
0 · Reply
lev57
lev57 May. 19 at 3:31 PM
$NRSN again the same method of forcibly lowering the paper rate. Every few sec . A portion of about 100 is sold and given at a rate of 0.77. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct.
0 · Reply
mmtiddy
mmtiddy May. 19 at 8:24 AM
$NRSN Smells like a company thats going to have a lot of R/S in the future to stay afloat
1 · Reply
Speculator2
Speculator2 May. 18 at 7:59 PM
$NRSN The science is bullish - the execution is bearish. They have yet to announce the closure and completion of the PIPE. They have still to announce the Alzheimer AD. When are they meeting with Canada regulators. Lots of delays and unknowns but the science is real and validated to a point it is published in respectable platforms and relayed by prestigious doctors.
0 · Reply
lev57
lev57 May. 18 at 7:46 PM
$NRSN again the same method of forcibly lowering the paper rate. Every few sec . A portion of about 100 is sold and given at a rate of 0.77. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct.
0 · Reply
lev57
lev57 May. 18 at 6:06 PM
$NRSN again the same method of forcibly lowering the paper rate. Every few minutes. A portion of about 100 is sold and given at a rate of 0.79. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct.
0 · Reply
lev57
lev57 May. 18 at 4:26 PM
$NRSN You have little faith. This company will succeed and bring good medicine to patients. It takes time. There are bumps along the way. But there is evidence of the company's performance to date.
1 · Reply
IrishSean
IrishSean May. 18 at 4:25 PM
$NRSN I gave the bulk case, here’s the bear case based on previous comms: Health Canada requests additional data pushing NDS submission to late 26 or early 27, partnership discussions extended further again or evaporate, Alzheimer’s data mixed, stock sells off into the event as it has done before. I’d say 40% probability of a genuine transformative event with partnership and NOC confirmation, 40% probability of meaningful progress without definitive closure on either, 20% probability of further delays framed positively…. It’s not a racing certainty by any means June is a multiple catalyst event. I tend towards slightly more bullish as per previous post but it’s a very speculative stock running on fumes.
0 · Reply
mmtiddy
mmtiddy May. 18 at 4:12 PM
$NRSN Alon has sucked the life out this company, I seriously do not understand why we need a whole movie trailer for a trial that will probably never start
0 · Reply
Latest News on NRSN
NeuroSense Announces Pricing of Insider-Led PIPE Financing

Apr 28, 2026, 2:30 PM EDT - 21 days ago

NeuroSense Announces Pricing of Insider-Led PIPE Financing

NRSN


PrimeC New Data to Be Presented at AD/PD™ 2026 Conference

Mar 18, 2026, 8:00 AM EDT - 2 months ago

PrimeC New Data to Be Presented at AD/PD™ 2026 Conference

NRSN


NeuroSense to Host Investor Webinar on December 8, 2025

Nov 3, 2025, 9:15 AM EST - 7 months ago

NeuroSense to Host Investor Webinar on December 8, 2025

NRSN


lev57
lev57 May. 19 at 7:29 PM
He changes that they will not exceed him in portions of 200. Who sells and buys immediately. In order to lower the rate. The SEC follows you. And a bill will come with you.$NRSN
1 · Reply
lev57
lev57 May. 19 at 4:18 PM
A gentleman gave 100. Who sells and buys immediately. In order to lower the rate. The SEC follows you. And a bill will come with you.$NRSN
0 · Reply
lev57
lev57 May. 19 at 3:31 PM
$NRSN again the same method of forcibly lowering the paper rate. Every few sec . A portion of about 100 is sold and given at a rate of 0.77. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct.
0 · Reply
mmtiddy
mmtiddy May. 19 at 8:24 AM
$NRSN Smells like a company thats going to have a lot of R/S in the future to stay afloat
1 · Reply
Speculator2
Speculator2 May. 18 at 7:59 PM
$NRSN The science is bullish - the execution is bearish. They have yet to announce the closure and completion of the PIPE. They have still to announce the Alzheimer AD. When are they meeting with Canada regulators. Lots of delays and unknowns but the science is real and validated to a point it is published in respectable platforms and relayed by prestigious doctors.
0 · Reply
lev57
lev57 May. 18 at 7:46 PM
$NRSN again the same method of forcibly lowering the paper rate. Every few sec . A portion of about 100 is sold and given at a rate of 0.77. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct.
0 · Reply
lev57
lev57 May. 18 at 6:06 PM
$NRSN again the same method of forcibly lowering the paper rate. Every few minutes. A portion of about 100 is sold and given at a rate of 0.79. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct.
0 · Reply
lev57
lev57 May. 18 at 4:26 PM
$NRSN You have little faith. This company will succeed and bring good medicine to patients. It takes time. There are bumps along the way. But there is evidence of the company's performance to date.
1 · Reply
IrishSean
IrishSean May. 18 at 4:25 PM
$NRSN I gave the bulk case, here’s the bear case based on previous comms: Health Canada requests additional data pushing NDS submission to late 26 or early 27, partnership discussions extended further again or evaporate, Alzheimer’s data mixed, stock sells off into the event as it has done before. I’d say 40% probability of a genuine transformative event with partnership and NOC confirmation, 40% probability of meaningful progress without definitive closure on either, 20% probability of further delays framed positively…. It’s not a racing certainty by any means June is a multiple catalyst event. I tend towards slightly more bullish as per previous post but it’s a very speculative stock running on fumes.
0 · Reply
mmtiddy
mmtiddy May. 18 at 4:12 PM
$NRSN Alon has sucked the life out this company, I seriously do not understand why we need a whole movie trailer for a trial that will probably never start
0 · Reply
lev57
lev57 May. 18 at 3:48 PM
Next June, the selection of the group to participate in the final trial that determines the effectiveness of the drug begins. People who registered for the conference will receive information on how the trial will be conducted. It will be conducted in several locations under supervision and monitoring.$NRSN
1 · Reply
rml360
rml360 May. 18 at 2:27 PM
$NRSN sorry this gives me no hope for any big deal to be announced next month, call me crazy
0 · Reply
IrishSean
IrishSean May. 17 at 9:16 AM
$NRSN Here’s a bullish take: Most Important phrase “additional data and insights that we expect to become publicly available by then”. “We expect” ie they have line of sight to something specific. “to become publicly available”, the information exists but not yet public domain. “by then” ie lands between now and June 24th. Agenda item four requires an answer, suggests early access, a partner or PARAGON enrollment. The CEO is presenting alone suggesting the update is strategic and commercial. What “Publicly Available By Then” probably refers to Health Canada pre NDS outcome. Second most likely, Health Canada outcome is almost certainly the precondition pre agreement signing. Third, Alzheimer’s RoAD publication. If the CEO delivers nothing, the backlash would be lasting. Lastly, the event banner image is not accidental design. That is a deliberate editorial choice about what kind of news is coming. Of course a bear case exists too.
1 · Reply
Speculator2
Speculator2 May. 16 at 5:17 PM
$NRSN The description in June 24th's event has been altered. It now contains a four points agenda and an important note on why it was rescheduled. The rescheduling to June 24 was deliberate, not arbitrary.
1 · Reply
IrishSean
IrishSean May. 16 at 8:17 AM
$NRSN One would be investor asked for a summary of where NRSN stands now. I’m no expert but imho they are at an interesting moment and sitting at a very dangerous juncture. The balance sheet is pretty much empty. It’s a bet, not a good investment term I know, on whether a catalyst (partnership, financing, regulatory win, AZ news) arrives before the money runs out. The market has priced in dilution and failure to execute. That’s the entire thesis without getting into all the science, mgt team etc etc etc
0 · Reply
lev57
lev57 May. 15 at 6:05 PM
again the same method of forcibly lowering the paper rate. Every few minutes. A portion of about 100 is sold and given at a rate of 0.82. In order to set a low rate. Together we can dismantle the system that is hurting us .A complaint was filed with the SEC about this conduct. $NRSN
0 · Reply
lev57
lev57 May. 15 at 4:33 PM
$NRSN Alon Ben-Noon writing . May is ALS Awareness Month. I think about the people I’ve met over the last decade - patients who measure progress not in years, but in the small things: holding their child, walking to a friend’s party, eating by themselves, hugging someone they love. ALS takes those things away one by one, and it does it fast. That urgency stays with me every day at NeuroSense Therapeutics. It’s why we measure ourselves not only by data, but by whether we are moving fast enough for the people who don’t have time to wait. To the patients, families, and caregivers carrying this every day - we see you, and we’re working for you. To the researchers, clinicians, and advocates pushing the science forward - Thank You. We are in this together. This month, and every month.
0 · Reply
Speculator2
Speculator2 May. 14 at 10:58 PM
$NRSN Phase 3 start — mid-2025 → late 2025 → summer 2026 AD data — Q1 2026 → Q2 2026 → unknown within Q2 Health Canada meeting — April → May Every single milestone has slipped June 24 is now carrying enormous weight as the culminating event for everything that has been delayed, including the partnership 17 months since binding sheet.
1 · Reply
boilerrm04
boilerrm04 May. 14 at 5:52 PM
$NRSN Looks like Biogen is moving ahead to phase 3 with their alz drug even though results arent that impressive but TAU markers being lower warrant drug progression so Prime C should publish their TAU numbers to see if better than Biogen.
1 · Reply
Speculator2
Speculator2 May. 14 at 2:33 PM
$NRSN Highest number of shares available to borrow. Either brokers released more shares, or shorts are less convinced and returned shares.
0 · Reply
Stekli27
Stekli27 May. 14 at 2:05 PM
$NRSN do we know when in May they are gonna have the meeting with HC?
1 · Reply
rml360
rml360 May. 14 at 1:48 PM
$NRSN my second attempt at warrants, I will buy 10k at .08, give me a day or so notice, and will put the funds in my account
0 · Reply